相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Late sodium current inhibition as a new cardioprotective approach
Sharon L. Hale et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure
Sharad Rastogi et al.
CARDIOLOGY (2008)
Effect of long-term monotherapy with the aldosterone receptor blocker eplerenone on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure
Sharad Rastogi et al.
CARDIOVASCULAR DRUGS AND THERAPY (2007)
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure
Valerio Zaca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure
Makoto Imai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Ranolazine: a novel agent that improves dysfunctional sodium channels
D. Q. Pham et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion
Peipei Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Chronic heart failure slows late sodium current in human and canine ventricular myocytes: Implications for repolarization variability
Victor A. Maltsev et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Global risk management in patients with type 2-diabetes mellitus
Michael H. Davidson
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts
Heather Fraser et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Antianginal efficacy of ranolazine when added to treatment with amlodipine - The ERICA (Efficacy of Ranolazine In Chronic Angina) Trial
Peter H. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction
Yejia Song et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
L. Belardinelli et al.
HEART (2006)
Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure
Hideaki Morita et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy
M Buitrago et al.
NATURE MEDICINE (2005)
Increased late sodium current in myocytes from a canine heart failure model and from failing human heart
CR Valdivia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris
MF Rousseau et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina
BR Chaitman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial
BR Chaitman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes
YJ Song et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment
HN Sabbah et al.
CIRCULATION RESEARCH (2003)
[Na+]i handling in the failing human heart
B Pieske et al.
CARDIOVASCULAR RESEARCH (2003)
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure
G Suzuki et al.
CIRCULATION (2002)
Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure
HN Sabbah et al.
JOURNAL OF CARDIAC FAILURE (2002)
Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure
H Morita et al.
CARDIOVASCULAR DRUGS AND THERAPY (2002)
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure
MP Chandler et al.
CIRCULATION RESEARCH (2002)
Overexpression of the Na+/Ca2+ exchanger and inhibition of the sarcoplasmic reticulum Ca2+-ATPase in ventricular myocytes from transgenic mice
CMN Terracciano et al.
CARDIOVASCULAR RESEARCH (2001)
Effects of dopamine β-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure
HN Sabbah et al.
CIRCULATION (2000)
分享论文
